Home/Filings/4/0001127602-20-000609
4//SEC Filing

Chan Gerald 4

Accession 0001127602-20-000609

CIK 0001492422other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:04 PM ET

Size

5.0 KB

Accession

0001127602-20-000609

Insider Transaction Report

Form 4
Period: 2020-01-01
Chan Gerald
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-01$30.62/sh+27,600$845,11227,600 total
    Exercise: $30.62Exp: 2029-12-31Common Stock (27,600 underlying)
Footnotes (1)
  • [F1]This option was granted January 1, 2020. The option vests quarterly over one year on the last day of each quarter from grant date.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001636579

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:04 PM ET
Size
5.0 KB